Literature DB >> 28656555

Search for key manifestations to predict inflammation on cardiac PET in suspected cardiac sarcoidosis population.

Vasileios Kouranos1, Kshama Wechalekar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28656555     DOI： 10.1007/s12350-017-0969-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  26 in total

1.  Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.

Authors:  Rami Yokoyama; Masao Miyagawa; Hideki Okayama; Takeshi Inoue; Hitoshi Miki; Akiyoshi Ogimoto; Jitsuo Higaki; Teruhito Mochizuki
Journal:  Int J Cardiol       Date:  2015-05-15       Impact factor: 4.164

2.  Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands.

Authors:  Jan-Peter Smedema; Gabriel Snoep; Marinus P G van Kroonenburgh; Robert-Jan van Geuns; Willem R M Dassen; Anton P Gorgels; Harry J G M Crijns
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

3.  Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.

Authors:  Vasileios Kouranos; George E Tzelepis; Aggeliki Rapti; Sofia Mavrogeni; Konstantina Aggeli; Marousa Douskou; Sanjay Prasad; Nikolaos Koulouris; Petros Sfikakis; Athol Wells; Elias Gialafos
Journal:  JACC Cardiovasc Imaging       Date:  2017-03-15

4.  Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.

Authors:  Hiroshi Ohira; David H Birnie; Elena Pena; Jordan Bernick; Brian Mc Ardle; Eugene Leung; George A Wells; Keiichiro Yoshinaga; Ichizo Tsujino; Takahiro Sato; Osamu Manabe; Noriko Oyama-Manabe; Masaharu Nishimura; Nagara Tamaki; Alexander Dick; Carole Dennie; Ran Klein; Jennifer Renaud; Robert A deKemp; Terrence D Ruddy; Benjamin J W Chow; Ross Davies; Renee Hessian; Peter Liu; Rob S B Beanlands; Pablo B Nery
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-11       Impact factor: 9.236

Review 5.  The diagnostic yield of implantable loop recorders in unexplained syncope: A systematic review and meta-analysis.

Authors:  Monica Solbiati; Giovanni Casazza; Franca Dipaola; Franca Barbic; Maja Caldato; Nicola Montano; Raffaello Furlan; Robert S Sheldon; Giorgio Costantino
Journal:  Int J Cardiol       Date:  2016-12-22       Impact factor: 4.164

6.  A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis.

Authors:  Yuji Okura; G William Dec; Joshua M Hare; Makoto Kodama; Gerald J Berry; Henry D Tazelaar; Kent R Bailey; Leslie T Cooper
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

7.  The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.

Authors:  Azadeh Ahmadian; Sumeet Pawar; Praveen Govender; Jeffrey Berman; Frederick L Ruberg; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2016-07-25       Impact factor: 5.952

8.  Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.

Authors:  Davendra Mehta; Steven A Lubitz; Zev Frankel; Juan P Wisnivesky; Andrew J Einstein; Martin Goldman; Josef Machac; Alvin Teirstein
Journal:  Chest       Date:  2008-03-13       Impact factor: 9.410

9.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Authors:  Ron Blankstein; Michael Osborne; Masanao Naya; Alfonso Waller; Chun K Kim; Venkatesh L Murthy; Pedram Kazemian; Raymond Y Kwong; Michifumi Tokuda; Hicham Skali; Robert Padera; Jon Hainer; William G Stevenson; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

10.  The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis.

Authors:  Osamu Manabe; Keiichiro Yoshinaga; Hiroshi Ohira; Atsuro Masuda; Takahiro Sato; Ichizo Tsujino; Asuka Yamada; Noriko Oyama-Manabe; Kenji Hirata; Masaharu Nishimura; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2015-08-05       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.